Nu-Med Plus, Inc. engages in the design, development, and marketing of technologies utilizing nitric oxide in the medical device field. The company is headquartered in Salt Lake City, Utah and currently employs 2 full-time employees. The company went IPO on 2013-08-02. The company focuses on the creation of a nitric oxide (NO) generating formulation, a hospital bedside NO delivery system, a clinical unit for use in medical clinics and rehabilitation centers and a mobile rechargeable device to deliver nitric oxide gas to offer solutions to hospitals, health systems and the medical community throughout the world. Hospital NO Unit delivers a continuous intra-breath concentration of therapeutic NO to patients who are on a ventilator in a hospital setting. The Clinical Delivery System is a simplified version of the hospital unit. Portable Delivery System delivers NO to the patient at prescribed intervals for 24 hours per day at controlled doses by means of a nasal cannula or a face mask. Reagent Delivery offers a range of concentrations and flow rates of NO.
Follow-Up Questions
¿Quién es el CEO de Nu-Med Plus Inc?
Mr. William Hayde es el Executive Chairman of the Board de Nu-Med Plus Inc, se unió a la empresa desde 2022.
¿Qué tal es el rendimiento del precio de la acción NUMD?
El precio actual de NUMD es de $0.0312, ha decreased un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Nu-Med Plus Inc?
Nu-Med Plus Inc pertenece a la industria N/A y el sector es N/A
¿Cuál es la capitalización bursátil de Nu-Med Plus Inc?
La capitalización bursátil actual de Nu-Med Plus Inc es $2.6M
